Edward C. Franklin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Edward C. Franklin (April 14, 1928 – February 20, 1982) was a pioneering American immunologist and physician.[1][2] He made major gains in the studies of the aging process with a discovery of a protein known as amyloid,[1][2] and played a key role in the fight against arthritis.[1][2][3] Franklin was a professor of medicine at the New York University School of Medicine,[1] a member of the National Academy of Sciences,[2] president of the American Society for Clinical Investigation,[1] and director of Irvington House Institute.[2] The New York Times called Franklin "an international authority on the human immune system".[1]

He discovered heavy chain disease, one type of which is named after him (Franklin's disease).[1][2] The Edward C. Franklin Award, which is given for achievements in immunology, has been established in his name.[4][5]

Life and career[edit]

Franklin was born in Berlin, Germany in 1928 and immigrated to the US in 1939 as an escapee from Nazism. He received his undergraduate degree from Harvard University in 1946 and his medical degree from the N.Y.U. School of Medicine in 1950.[1]

External links[edit]


  1. ^ a b c d e f g h New York Times:DR. EDWARD C. FRANKLIN DIES; HUMAN-IMMUNOLOGY PIONEER,by WALTER H. WAGGONER, February 25, 1982
  2. ^ a b c d e f National Academies Press, Biographical Memoirs, V.78, EDWARD C. FRANKLIN, BY HENRY METZGER
  3. ^ New York Times:GAIN IS REPORTED IN ARTHRITIS FIGHT; Experiments Have Isolated Rheumatoid Factor;By BESS FURMAN,December 07, 1957,
  4. ^ The 1983 Edward C. Franklin Award for distinguished achievements in basic and clinical immunology,Angelo O. Carbonara
  5. ^ Weissmann, Gerald. "Edward C. Franklin 1928–1982". Arthritis & Rheumatism. 25: 1029. doi:10.1002/art.1780250826.